+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 74 Pages
  • March 2023
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5778910
The North America Gabapentin Market should witness market growth of 3.8% CAGR during the forecast period (2022-2028).

Gabapentin is one of the two medications used in the PROMETA protocol of treatment formethamphetamine,cocaine, and alcoholaddiction. When taken in a dosage of 1200 milligrams, reports indicate that gabapentin has the potential to minimize the severity of symptoms of withdrawal as well as cravings caused by stopping the intake or usage of methamphetamine. Also, it minimizes the symptoms of withdrawal and assists those who are addicted to the medicines that are prescribed.

In addition, gabapentin has recently been shown to be effective in treating various conditions related to the nervous system. In recent years, gabapentin has become one of the most consumed and prescribed drugs. The increasing usecan be ascribed to elements like the rising prevalence of seizures and neuropathic pain, as well as the rising use of the medicine as a pain reliever. In addition, the growing elderly population, increased government activities, andpharmaceutical corporations' R&D spendingare further motivators. Gabapentin is an anticonvulsant typically provided to people with epilepsy to control their seizure activity.

In North America,epilepsy care is hampered by the lack of quality, quantity, and availability of diagnostic tools, medications, specialists, resources,and facilities. There is little public knowledge of epilepsy, which is more prevalent than Parkinson's disease,multiple sclerosis, or autism. Consequently, in recent years, the regional governments have been putting more effort into raising awareness about epilepsy. Such efforts have resulted in greater attention to the care of epileptics, facilitating the ease of drug accessibility. Therefore, the growing demand for gabapentin to treat epilepsy will accelerate the market's growth in the coming years.

The US market dominated the North America Gabapentin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $719.8 million by 2028. The Canada market is poised to grow at a CAGR of 6.2% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 5.2% during (2022-2028).

Based on Application, the market is segmented into Epilepsy, Restless Legs Syndrome, Neuropathic Pain, and Others. Based on Dosage Form, the market is segmented into Capsule, Tablet and Oral Solution. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Aurobindo Pharma Limited, Amneal Pharmaceuticals, Inc., Cipla Limited, and Apotex, Inc.

Scope of the Study

By Application

  • Epilepsy
  • Restless Legs Syndrome
  • Neuropathic Pain
  • Others

By Dosage Form

  • Capsule
  • Tablet
  • Oral Solution

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Zydus Lifesciences Ltd.
  • Glenmark Pharmaceuticals Limited
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Aurobindo Pharma Limited
  • Amneal Pharmaceuticals, Inc.
  • Cipla Limited
  • Apotex, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Gabapentin Market, by Application
1.4.2 North America Gabapentin Market, by Dosage Form
1.4.3 North America Gabapentin Market, by Distribution Channel
1.4.4 North America Gabapentin Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Gabapentin Market by Application
3.1 North America Epilepsy Market by Country
3.2 North America Restless Legs Syndrome Market by Country
3.3 North America Neuropathic Pain Market by Country
3.4 North America Others Market by Country
Chapter 4. North America Gabapentin Market by Dosage Form
4.1 North America Capsule Market by Country
4.2 North America Tablet Market by Country
4.3 North America Oral Solution Market by Country
Chapter 5. North America Gabapentin Market by Distribution Channel
5.1 North America Hospital Pharmacy Market by Country
5.2 North America Retail Pharmacy Market by Country
5.3 North America Online Pharmacy Market by Country
Chapter 6. North America Gabapentin Market by Country
6.1 US Gabapentin Market
6.1.1 US Gabapentin Market by Application
6.1.2 US Gabapentin Market by Dosage Form
6.1.3 US Gabapentin Market by Distribution Channel
6.2 Canada Gabapentin Market
6.2.1 Canada Gabapentin Market by Application
6.2.2 Canada Gabapentin Market by Dosage Form
6.2.3 Canada Gabapentin Market by Distribution Channel
6.3 Mexico Gabapentin Market
6.3.1 Mexico Gabapentin Market by Application
6.3.2 Mexico Gabapentin Market by Dosage Form
6.3.3 Mexico Gabapentin Market by Distribution Channel
6.4 Rest of North America Gabapentin Market
6.4.1 Rest of North America Gabapentin Market by Application
6.4.2 Rest of North America Gabapentin Market by Dosage Form
6.4.3 Rest of North America Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent Strategies and Developments
7.1.5.1 Trials and approvals
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Acquisition and Mergers
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent Strategies and Developments
7.6.5.1 Partnerships, Collaborations, and Agreements
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview

Companies Mentioned

  • Zydus Lifesciences Ltd.
  • Glenmark Pharmaceuticals Limited
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Aurobindo Pharma Limited
  • Amneal Pharmaceuticals, Inc.
  • Cipla Limited
  • Apotex, Inc.

Methodology

Loading
LOADING...